Invention Grant
- Patent Title: Methods of treating prurigo nodularis using anti-IL-31RA antibody compositions
-
Application No.: US16804475Application Date: 2020-02-28
-
Publication No.: US11312779B2Publication Date: 2022-04-26
- Inventor: Janine M. Bilsborough
- Applicant: ZymoGenetics, Inc.
- Applicant Address: US NJ Princeton
- Assignee: ZymoGenetics, Inc.
- Current Assignee: ZymoGenetics, Inc.
- Current Assignee Address: US NJ Princeton
- Agent Brian J. Walsh
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; C07K14/715
Abstract:
The present invention relates to methods of treating patients suffering from Contact dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia aereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus, or combination by administering an IL-31RA antagonist.
Public/Granted literature
- US20200239581A1 METHODS OF TREATING PRURIGO NODULARIS USING ANTI-IL-31RA ANTIBODY COMPOSITIONS Public/Granted day:2020-07-30
Information query
